NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637113. A total of 35 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,000 | +50.0% | 50,000 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | +500.0% | 50,000 | +4900.0% | 0.00% | – |
| Q4 2021 | $1,000 | -96.9% | 1,000 | -96.2% | 0.00% | – |
| Q3 2021 | $32,000 | +3100.0% | 26,500 | +5200.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|